XML 28 R16.htm IDEA: XBRL DOCUMENT v3.6.0.2
Investments in and Advances to Unconsolidated Joint Ventures
12 Months Ended
Dec. 31, 2016
Investments in and Advances to Unconsolidated Joint Ventures  
Investments in and Advances to Unconsolidated Joint Ventures

 

NOTE 8.    Investments in and Advances to Unconsolidated Joint Ventures

The Company owns interests in the following entities that are accounted for under the equity method (dollars in thousands):

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

Carrying Amount

 

 

 

 

 

 

 

December 31,

 

Entity(1)

    

Segment

    

Ownership %

    

2016

 

2015

 

CCRC JV(2)

 

SHOP

 

49

 

$

439,449

 

$

465,179

 

MBK JV(3)

 

SHOP

 

50

 

 

38,909

 

 

34,131

 

HCP Ventures III, LLC

 

Medical office

 

30

 

 

1,533

 

 

9,241

 

HCP Ventures IV, LLC

 

Medical office

 

20

 

 

7,277

 

 

11,884

 

HCP Life Science(4)

 

Life science

 

50-63

 

 

67,879

 

 

68,582

 

Vintage Park

 

SHOP

 

85

 

 

7,486

 

 

8,729

 

MBK Development JV(3)

 

SHOP

 

50

 

 

2,463

 

 

2,224

 

Suburban Properties, LLC

 

Medical office

 

67

 

 

4,628

 

 

4,621

 

K&Y(5)

 

Other

 

80

 

 

1,342

 

 

 —

 

Advances to unconsolidated joint ventures, net and other

 

 

 

 

 

 

525

 

 

653

 

 

 

 

 

 

 

$

571,491

 

$

605,244

 


(1)

These entities are not consolidated because the Company does not control, through voting rights or other means, the joint ventures.

(2)

Includes two unconsolidated joint ventures in a RIDEA structure (CCRC PropCo and CCRC OpCo).

(3)

Includes two unconsolidated joint ventures in a RIDEA structure (PropCo and OpCo).

(4)

Includes three unconsolidated joint ventures between the Company and an institutional capital partner for which the Company is the managing member. HCP Life Science includes the following partnerships (and the Company’s ownership percentage): (i) Torrey Pines Science Center, LP (50%); (ii) Britannia Biotech Gateway, LP (55%); and (iii) LASDK, LP (63%).

(5)

Includes three unconsolidated joint ventures.

 

MBK JV

On March 30, 2015, the Company and MBK Senior Living (“MBK”), a subsidiary of Mitsui & Co. Ltd, formed a new RIDEA joint venture (“MBK JV”) that owns three senior housing facilities with the Company and MBK each owning a 50% equity interest. MBK manages these communities on behalf of the joint venture. The Company contributed $27 million of cash and MBK contributed the three senior housing facilities with a fair value of $126 million, which were encumbered by $78 million of mortgage debt at closing.

HCP Ventures III, LLC and HCP Ventures IV, LLC

On December 30, 2015, HCP Ventures III, LLC (“HCP Ventures III”) and HCP Ventures IV, LLC (“HCP Ventures IV”) sold 61 MOBs, three hospitals and a re-development property for total proceeds of $634 million, recognizing gains on sales of real estate of $59 million, of which the Company’s share was $15 million. As part of these sales, the Company received aggregate distributions of $45 million, including repayment of its loan receivable. During the quarter ended December 31, 2016, HCP Ventures III sold the remaining three assets in its portfolio for $31 million, recognizing gains on sales of real estate of $4.9 million, of which the Company’s share was $1.3 million. As part of this sale, the Company received aggregate distributions of $8 million.